Lezárult
Integrated PK/efficacy, safety, and immunogenicity study to demonstrate similarity of JPB898, a proposed biosimilar to nivolumab, to Opdivo® in combination with Yervoy®
NCT06587451· 3. fázis· H e x a l AG· Forrás
Lezárult
Long-Term Extension Study (AtDvance) to Evaluate the Safety and Efficacy of GSK1070806 in Participants with Moderate to Severe Atopic Dermatitis.
NCT06447506· 2. fázis· Glaxosmithkline Research & Development Limited· Forrás
Lezárult
A Phase 2 Dose-Finding Study to Assess the Safety and Effectiveness of Tovinontrine in Patients With Chronic Heart Failure With Reduced Ejection Fraction
2023-508736-62-00· 2. fázis· Cardurion Pharmaceuticals Inc.· Forrás
Lezárult
A study to find how well Dazodalibep works and how safe it is in participants with Sjögren’s Syndrome
2023-503923-24-00· 3. fázis· Horizon Therapeutics Ireland Designated Activity Company· Forrás
Lezárult
Testing a New Medication (Etrinabdiona) for Leg Circulation disease: A Study of Safety, Tolerability and Preliminary Efficacy
2023-509452-34-00· 2. fázis· Vivacell Biotechnology Espana S.L.· Forrás
Lezárult
A study to investigate the efficacy and safety of luveltamab tazevibulin versus IC chemotherapy in women with ovarian cancer (including fallopian tube or primary peritoneal cancers) expressing FOLR1
NCT05870748· 2. fázis· Sutro Biopharma Inc.· Forrás
Leállították
A Study to Test Long-term Treatment With Spesolimab in People With a Skin Condition Disease Called Hidradenitis Suppurativa (HS) Who Took Part in a Previous Study With Spesolimab
NCT06241573· 2/3. fázis· Boehringer Ingelheim· Forrás
Lezárult
Efficacy, Safety and Tolerability of Balcinrenone/Dapagliflozin Compared to Dapagliflozin in Adults With Chronic Kidney Disease
NCT06350123· 2. fázis· AstraZeneca· Forrás
Lezárult
Safety & Effectiveness of Tovinontrine in Chronic Heart Failure With Preserved Ejection Fraction (Cycle-2-PEF)
NCT06215586· 2. fázis· Cardurion Pharmaceuticals, Inc.· Forrás
Fut, nem toboroz
A 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Participants With Nonsegmental Vitiligo
NCT06163326· 3. fázis· Pfizer· Forrás
Lezárult
Phase 2b Study to Investigate the Safety and Efficacy of TIN816 in Sepsis-associated Acute Kidney Injury (CLEAR-AKI)
NCT05996835· 2. fázis· Novartis Pharmaceuticals· Forrás
Lezárult
A study to investigate response to ompenaclid combined with FOLFIRI plus bevacizumab in patients with advanced or metastatic colorectal cancer
2023-503356-27-00· 2. fázis· Inspirna Inc.· Forrás
Lezárult
A Study of Immune Checkpoint Inhibitor Combinations With Axitinib in Patients with Previously Untreated Locally Advanced Unresectable or Metastatic Renal Cell Carcinoma
2023-505816-39-00· 2. fázis· F. Hoffmann-La Roche AG· Forrás
Lezárult
Single arm phase II study of the efficacy and safety of the combination of Trastuzumab plus TUCAtinib plus viNorelbine in patients with HER2-positive non-resectable locally advanced or metastatic breast cancer “TrasTUCAN Study”
NCT05583110· 1/2. fázis· Fundacion Grupo Espanol De Investigacion En Cancer De Mama· Forrás
Lezárult
Phase 3 Study to Assess Efficacy and Safety of Batoclimab as Induction and Maintenance Therapy in Adult Participants with Generalized Myasthenia Gravis (gMG)
2024-512258-91-00· 3. fázis· Immunovant Sciences GmbH· Forrás
Lezárult
Phase IV, a Clinical Trial to Assess Safety and Convenience of the Change From DTG/3TC to BIC/FTC/TAF in People With HIV, Good Virological Control and Neuropsychiatric Vulnerabilities
NCT05549180· 4. fázis· Fundacion SEIMC-GESIDA· Forrás
Lezárult
A Study of Ustekinumab or Guselkumab in Pediatric Participants With Active Juvenile Psoriatic Arthritis
NCT05083182· 3. fázis· Janssen Research & Development, LLC· Forrás
Lezárult
Safety Study of CC-93538 in Adult and Adolescent Participants With Eosinophilic Esophagitis
NCT04991935· 3. fázis· Celgene· Forrás
Lezárult
A Study of Eptinezumab in Participants With Migraine and Medication Overuse Headache
NCT05452239· 4. fázis· H. Lundbeck A/S· Forrás
Lezárult
Phase 2 Study of ALXN2050 in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN)
NCT05097989· 2. fázis· Alexion Pharmaceuticals Inc.· Forrás
Lezárult
A Study of Olezarsen (ISIS 678354) Administered to Participants With Severe Hypertriglyceridemia.
2021-002192-19· 3. fázis· Ionis Pharmaceuticals Inc.· Forrás
Lezárult
Study to Investigate Alternative Dosing Regimens of Belantamab Mafodotin in Participants With Relapsed or Refractory Multiple Myeloma
NCT05064358· 2. fázis· GlaxoSmithKline· Forrás
Leállították
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age
NCT05085366· 3. fázis· ModernaTX, Inc.· Forrás
Lezárult
Study to assess the efficacy and safety of alpelisib in combination with olaparib in participants with platinum-resistant or refractory gBRCAnm HGSOC
NCT04729387· 3. fázis· Novartis Pharma AG· Forrás
Lezárult
Study to Evaluate the Long-Term Efficacy and Safety of the Investigational Drug LIB003 for the Reduction of Cholesterol in Patients with Homozygous and Heterozygous Familial Hypercholesterolemia, Cardiovascular Disease, or at High Risk for Cardiovascular Disease.
NCT04798430· 3. fázis· Lib Therapeutics LLC· Forrás
Lezárult
ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation
NCT05021835· 3. fázis· Novo Nordisk A/S· Forrás
Lezárult
A Study to Test the Efficacy, Safety, and Tolerability of Bepranemab (UCB0107) in Patients With Mild Cognitive Impairment or Mild Alzheimer's Disease (AD)
NCT04867616· 2. fázis· UCB Biopharma SRL· Forrás
Lezárult
Eptinezumab as Preventive Treatment of Migraine in Adults With Migraine
NCT04921384· 3. fázis· H. Lundbeck A/S· Forrás
Fut, nem toboroz
A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer
NCT04486378· 2. fázis· BioNTech SE· Forrás
Fut, nem toboroz
Myasthenia Gravis Inebilizumab Trial
NCT04524273· 3. fázis· Amgen· Forrás
Lezárult
Efficacy and Safety of Tildrakizumab Compared to Placebo in Subjects With Active Psoriatic Arthritis I (INSPIRE 1)
NCT04314544· 3. fázis· Sun Pharmaceutical Industries Limited· Forrás
Lezárult
A Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Subjects With Active Axial Spondyloarthritis Including Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis
NCT04436640· 3. fázis· UCB Biopharma SRL· Forrás
Lezárult
An efficacy and safety study of 2-OHOA in patients with glioblastoma
2024-511542-39-00· 2/3. fázis· Laminar Pharmaceuticals S.A.· Forrás
Lezárult
A Study to Assess the Long-term Safety, Tolerability, and Efficacy of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis
NCT04009499· 3. fázis· UCB Biopharma SRL· Forrás
Lezárult
Long-Term Study That Measures the Safety and Efficacy of Deucravacitinib (BMS-986165) in Participants With Psoriasis
NCT04036435· 3. fázis· Bristol-Myers Squibb· Forrás
Lezárult
Long-Term PF-06651600 for the Treatment of Alopecia Areata
NCT04006457· 3. fázis· Pfizer· Forrás
Lezárult
Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke
NCT03872401· 3. fázis· Amgen· Forrás
Lezárult
"Safety, efficacy, immunogenicity study of GSK Biologicals’ HBV viral vector and adjuvanted proteins vaccine (GSK3528869A) in adult patients with chronic Hepatitis B infection.
"
NCT03866187· 1/2. fázis· GlaxoSmithKline Biologicals· Forrás
Fut, nem toboroz
A Global Study to Evaluate Transarterial Chemoembolization (TACE) in Combination With Durvalumab and Bevacizumab Therapy in Patients With Locoregional Hepatocellular Carcinoma
NCT03778957· 3. fázis· AstraZeneca· Forrás
Lezárult
A Phase 3 Study of Nivolumab versus Placebo for Participants with Hepatocellular Cancer Who Are at High Risk of Recurrence after Hepatic Resection or Ablation
2023-508726-10-00· 3. fázis· Bristol-Myers Squibb Services Unlimited Company· Forrás
Lezárult
Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
NCT03422822· 3. fázis· Pfizer· Forrás
Fut, nem toboroz
A Study of Niraparib (GSK3985771) Maintenance Treatment in Participants With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy
NCT02655016· 3. fázis· Tesaro, Inc.· Forrás
Lezárult
A study of nivolumab or placebo in patients following removal of their esophageal or gastroesophageal junction cancer.
NCT02743494· 3. fázis· Bristol Myers Squibb International Corporation· Forrás
Fut, nem toboroz
A Study of Apalutamide (JNJ-56021927, ARN-509) Plus Androgen Deprivation Therapy (ADT) Versus ADT in Participants With mHSPC
NCT02489318· 3. fázis· Aragon Pharmaceuticals, Inc.· Forrás
Lezárult
Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer [IMpower010]
NCT02486718· 3. fázis· Hoffmann-La Roche· Forrás